Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eletriptan Early Intervention in Migraine
NCT00174395Phase 4Completed
- Sponsor
- Viatris
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of eletriptan in migraine (2 arms), sponsored by Viatris. Primary endpoint: Pain free response at 2 hours. Started Mar 2005; status: completed.
02
Drugs
eletriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00174395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174395.